LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization
2026-08-03
This study elucidates how LAMP1 controls the CXCL10-CXCR3 axis, mediating macrophage polarization in both inflammatory and non-inflammatory contexts. The findings reveal context-dependent roles for CXCR3 signaling in regulating autophagy and macrophage phenotype, informing new strategies for inflammation research.
Metformin Hydrochloride: Mechanistic Insights Beyond Diabete
2026-08-03
Explore the multifaceted scientific mechanisms of Metformin Hydrochloride (Metformin HCl), including AMPK signaling and Wnt/β-catenin modulation. This article delivers advanced perspectives for metabolic, musculoskeletal, and stem cell research applications.
Phosphatase Inhibitor Cocktail 1 (100X in DMSO): Workflow Gu
2026-08-02
Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is designed to prevent protein dephosphorylation during sample processing, making it essential for accurate phosphoproteomic and signaling pathway studies. It is not intended for diagnostic or therapeutic use, and is best applied in workflows where preservation of endogenous phosphorylation is critical.
Tivozanib (AV-951): Redefining VEGFR Inhibition in Translati
2026-08-01
Explore how Tivozanib (AV-951) is reshaping anti-angiogenic therapy and translational oncology through mechanistic precision, advanced in vitro methodologies, and strategic guidance. This article offers in-depth insights into optimizing experimental design, benchmarking clinical outcomes, and envisioning the next frontiers in renal cell carcinoma treatment and beyond.
PDK4-IN-1 Hydrochloride: Driving Translational Mitochondrial
2026-07-31
A strategic exploration of PDK4-IN-1 hydrochloride’s mechanistic and translational leverage, bridging mitochondrial metabolism research with actionable guidance for metabolic, cardiac, and oncology investigators. The article integrates new insights from recent medicinal chemistry advances, highlights protocol best practices, and offers a vision for next-generation metabolic modulation.
Ganetespib (STA-9090): Disrupting Hsp90 for Translational On
2026-07-31
This thought-leadership article explores how Ganetespib (STA-9090), a next-generation triazolone-containing Hsp90 inhibitor from APExBIO, enables translational researchers to interrogate and disrupt oncogenic signaling networks. It integrates mechanistic insights into Hsp90 chaperone function, client protein dependencies, and emerging intersections with programmed cell death and unconventional protein secretion. By critically appraising recent findings and offering strategic guidance, the article charts a roadmap for leveraging Ganetespib in advanced cancer research, going beyond standard product narratives.
Belinostat (PXD101): Optimizing HDAC Inhibition in Cancer As
2026-07-30
Belinostat (PXD101) delivers precise pan-HDAC inhibition and robust epigenetic modulation, empowering cancer researchers to dissect proliferation suppression and cell death in tumor models. This guide translates recent methodological advances into stepwise workflows, troubleshooting strategies, and real-world protocol enhancements for maximum research impact.
AAL-993: Precision VEGF Receptor Inhibitor for Tumor Angioge
2026-07-30
AAL-993 delivers potent, selective VEGF receptor inhibition for high-fidelity tumor angiogenesis and metastasis modeling. This guide details stepwise experimental workflows, troubleshooting insights, and translational opportunities—empowering oncology researchers to drive reproducible and insightful anti-angiogenic studies.
LMO2–LDB1 Complex Drives AML Progression via Oncogenic Syner
2026-07-29
This study elucidates how the LMO2–LDB1 protein complex promotes proliferation and survival in acute myeloid leukemia (AML) cells. Through genetic, biochemical, and genomic analyses, the research uncovers the mechanistic role of this complex, establishing it as a promising molecular target for AML intervention.
pH-Dependent Lassa Virus Spike Changes and Inhibition Mechan
2026-07-29
Katz et al. delineate the sequence of pH-driven conformational changes in the Lassa virus spike complex, revealing how these facilitate cell entry and can be antagonized by a novel entry inhibitor. This work provides high-resolution mechanistic insight essential for the rational design of therapeutics targeting arenavirus fusion machinery.
HNRNPU K181 Lactylation Orchestrates Serine Metabolism in Ce
2026-07-28
This study identifies lysine 181 lactylation of HNRNPU as a pivotal post-translational modification that stabilizes PHGDH mRNA and drives serine metabolic reprogramming in cervical cancer. The results reveal a dynamic interplay between lactylation and acetylation at HNRNPU K181, providing insight into tumor metabolic vulnerabilities and highlighting new opportunities for targeted intervention.
DMXAA (Vadimezan): Applied Workflows for Tumor Vascular Disr
2026-07-28
DMXAA (Vadimezan) enables targeted tumor vascular disruption by inhibiting DT-diaphorase and VEGFR2, acting as a potent apoptosis inducer in cancer biology research. This guide delivers actionable experimental protocols, advanced applications, and troubleshooting strategies for maximizing DMXAA's translational impact, anchored by insights from recent nanomedicine innovations.
Cycloheximide: Protein Biosynthesis Inhibitor in Research
2026-07-27
Cycloheximide is a potent protein biosynthesis inhibitor widely used to study translational control, apoptosis, and protein turnover in eukaryotic cells. Its specificity and solubility make it an essential tool for apoptosis assays and disease modeling in experimental research.
Standardized Whole-Blood Assay for Immunometabolic Modulatio
2026-07-27
This protocol paper introduces a reproducible approach for analyzing immune responses in fresh human whole blood under defined metabolic modulation. By integrating selective metabolic inhibitors, the study enables precise dissection of how cellular metabolism shapes cytokine production, offering a powerful platform for immunometabolism research and translational immune profiling.
Methicillin Sodium Salt: Optimizing MSSA Research Workflows
2026-07-26
Methicillin sodium salt remains an indispensable benchmark for Staphylococcus aureus infection research and antibiotic susceptibility testing, despite the rise of MRSA. This guide delivers evidence-driven protocol enhancements, troubleshooting strategies, and comparative insights to maximize experimental rigor and reproducibility.
464 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page